Roskies E, Kearney H, Spevack M, Surkis A, Cohen C, Gilman S
J Behav Med. 1979 Jun;2(2):195-207. doi: 10.1007/BF00846666.
To test the reliability and durability of positive treatment effects obtained in a type A intervention project for healthy managers, the analysis was extended to data available from a third treatment group (a special behavior therapy group for participants eliminated from the main sample because of manifestations of clinical CHD) and to measures obtained 6 months following the end of treatment. Immediately after treatment all three groups showed a similar pattern of improvement, although the two behavior therapy groups did show a greater decrease in serum cholesterol levels. Six months after treatment the sample as a whole showed good maintenance of treatment effects, but the differences between groups had become somewhat sharper, with the special behavior therapy group faring best, the regular behavior therapy group intermediate, and the psychotherapy group worst. The logical consistency of these findings increases our confidence in the initial treatment results, as well as permitting cautious optimism concerning the possibility of developing effective intervention programs for coronary-type (type A) behavior.
为了检验在一项针对健康管理者的A型干预项目中所获得的积极治疗效果的可靠性和持久性,分析范围扩大到了来自第三个治疗组(一个针对因临床冠心病表现而被排除在主要样本之外的参与者的特殊行为治疗组)的数据,以及治疗结束6个月后所获得的测量结果。治疗结束后立即发现,所有三个组都呈现出相似的改善模式,尽管两个行为治疗组的血清胆固醇水平下降幅度确实更大。治疗6个月后,整个样本显示出治疗效果得到了良好维持,但组间差异变得更加明显,特殊行为治疗组效果最佳,常规行为治疗组居中,心理治疗组最差。这些研究结果在逻辑上的一致性增强了我们对初始治疗结果的信心,同时也让我们对开发针对冠心病型(A型)行为的有效干预项目的可能性持谨慎乐观态度。